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a  b  s  t  r  a  c  t
The  therapeutic  efﬁcacy  of eprinomectin  in  an  extended-release  injection  (ERI) formula-
tion was evaluated  against  induced  infections  of developing  fourth-stage  larval  or adult
gastrointestinal  and  pulmonary  nematodes  of  cattle  in  a series  of  six  studies  under  two
identical  protocols  (three  each  for developing  fourth-stage  larvae  or  adults)  conducted  in
the USA,  Germany  or  the  UK  (two  studies  at each  location,  one  per stage).
Each  study  initially  included  16  nematode-free  cattle.  The  cattle  were  of various  breeds  or
crosses, weighed  109–186.5  kg prior  to  treatment,  and  were  approximately  4–7  months  old.
The animals  were  blocked  based  on  pre-treatment  bodyweight  and  then  randomly  allocated
to treatment:  eprinomectin  ERI vehicle  (control)  at 1  mL/50  kg body  weight  or eprinomectin
5% ERI  at  1 mL/50  kg bodyweight  (1.0 mg  eprinomectin/kg)  for a total  of eight  and  eight
animals  in  each  group.  Treatments  were  administered  once  on Day  0 by  subcutaneous
injection  in  front  of  the  shoulder.
In each  study,  cattle were  infected  with  a  combination  of  infective  third-stage  larvae
or  eggs  of  gastrointestinal  and  pulmonary  nematodes.  Inoculation  was  scheduled  so  that
the nematodes  were  expected  to be  fourth-stage  larvae  or adults  at the  time  of  treatment.
For parasite  recovery,  all  study  animals  were  humanely  euthanized  and  necropsied  14–15
(adult infections)  or 21–22  days  after  treatment  (developing  fourth-stage  larval  infections).
When compared  with  the  vehicle-treated  control  counts,  efﬁcacy  of eprinomectin  ERI
against developing  fourth-stage  larvae  and  adults  was  ≥98%  (p < 0.05)  for  the follow-
ing  nematodes:  Dictyocaulus  viviparus,  Bunostomum  phlebotomum,  Cooperia  curticei,  C.
oncophora,  C. surnabada,  C. punctata,  Haemonchus  contortus,  H. placei,  Nematodirus  helve-
tianus,  Oesophagostomum  radiatum,  Oes.  venulosum,  Ostertagia  leptospicularis,  O.  ostertagi,
O. circumcincta,  O.  pinnata,  O.  trifurcata  (developing  fourth-stage  larval  infections  only),
Strongyloides  papillosus,  Trichostrongylus  axei,  T.  colubriformis,  and  Trichuris  ovis  (adult  infec-
tions only).
All animals  accepted  the  treatment  well.  No  adverse  reaction  to  treatments  was  observed
in any  animal  in  any  study.
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1. Introduction
Open access under CC BY-NC-ND license.As documented in numerous publications, epri-
nomectin, the most recent commercialized compound
of the macrocyclic lactone class of parasiticides used in
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a 0.5% pour-on formulation at 0.5 mg  eprinomectin/kg
bodyweight, is highly effective against infections with
gastrointestinal and pulmonary nematodes, chorioptic
and sarcoptic mange mites, biting and sucking lice infes-
tations, and larvae stages of cattle grubs (Shoop et al.,
1996; Barth et al., 1997; Gogolewski et al., 1997a, 1997b;
Holste et al., 1997, 1998; Pitt et al., 1997; Williams et al.,
1997; Yazwinski et al., 1997; Schönberg et al., 2000;
Watson and Forbes, 2000; Campbell et al., 2001; Schoett
et al., 2002; Rehbein et al., 2005). Dose titration studies
have demonstrated that eprinomectin represents some
threefold greater potency against gastrointestinal nema-
todes than ivermectin (Shoop and Soll, 2002), and egg
count reductions occurred faster in cattle treated with
eprinomectin than in animals treated with other topical
macrocyclic lactones products (Baggott et al., 1999). The
eprinomectin pour-on formulation has a persistent activity
of up to 28 days against important bovine nematodes,
e.g., Cooperia spp., Nematodirus helvetianus and Ostertagia
ostertagi (Cramer et al., 2000; Holste et al., 2002) and
hence has been used successfully in strategic programs for
controlling gastrointestinal nematodes and lungworms
in cattle (Batty et al., 1999; Epe et al., 1999; Dorny et al.,
2000).
The suitability of eprinomectin as an injectable
anthelmintic for cattle has been demonstrated in titra-
tion experiments using an experimental propylene gly-
col/glycerol formal (60:40) based formulation (Shoop et al.,
2001).
In order to extend the persistent activity of epri-
nomectin against endoparasites, an injectable formulation
has been developed which releases the active in concentra-
tions to provide effective control of nematode infections
in cattle for up to 150 days after treatment (Soll et al.,
2013). In this extended-release formulation, eprinomectin
is released from a matrix formed with poly(d,l-lactide-co-
glycolic)acid (PLGA). PLGA is known as a safe and effective
biodegradable material which has been assessed as a drug
delivery system for extended release applications of vari-
ous pharmaceutical compounds in human and veterinary
medicines including macrocyclic lactones (Lewis, 1990;
Miller et al., 1999; Clark et al., 2004; Winzenburg et al.,
2004).
The studies reported here were designed to determine
the therapeutic efﬁcacy of eprinomectin extended-release
injection (ERI) against established infections with normally
developing larval and adult gastrointestinal and pulmonary
nematode parasites of cattle.
2. Materials and methods
A total of six controlled studies were conducted, two
each in the USA (Studies 1 and 4), in Germany (Studies 2 and
5), and in the UK (Studies 3 and 6). Three studies each were
conducted under the same protocol to conﬁrm the efﬁcacy
either against developing fourth-stage larval (Studies 1–3)
or against adult nematode parasites (Studies 4–6).The studies were designed and conducted to comply
with the regulatory requirements of both the FDA/CVM
and the European Medicines Agency/Committee for Medic-
inal Products for Veterinary Use, and according to relevantology 192 (2013) 338– 345 339
guidelines for good clinical practices (GCPs) and for estab-
lishing the efﬁcacy of cattle anthelmintics.
The studies were performed as blinded studies, i.e., all
personnel involved in collecting data were masked to the
treatment assignment of the animals.
2.1. Experimental animals
The animal descriptions and details are presented in
Table 1. A total of 48 (32 male, 16 male castrate) healthy,
ruminating Holstein, Braunvieh (Brown Swiss), Limousin,
Limousin cross, or Brown Swiss cross cattle were included
in each series of three studies. The animals weighed
109–167.4 kg prior to treatment (Day –1) and were 4–6
months old in Studies 1–3; animals used in Studies 4–6
weighed 124.5–186.5 kg prior to treatment (Day –1) and
were approximately 5–7 months old. Animals had not
been treated previously with an avermectin or milbemycin
product and were not shedding gastrointestinal nematode
eggs and lungworm larvae as conﬁrmed by standard fecal
examination techniques (quantitative fecal egg count and
Baermann techniques) 15–36 days prior to initial larval
inoculation.
In all studies, cattle were held indoors to preclude
unintentional nematode infection and were housed indi-
vidually, for a minimum of two  weeks before treatment
until the end of the study. The environmental conditions
were identical for all animals within a study. The animals
were fed according to local practice, the same for each ani-
mal  within each study. Drinking water was available at all
times. Animals were handled with due regard to their wel-
fare and in compliance with Merial Institutional Animal
Care and Use Committee (IACUC) approvals, any applicable
local regulations, and requirements of any local IACUC.
2.2. Induced nematode infections
The cattle were inoculated with a combination of
infective third-stage larvae or eggs (Trichuris ovis) of
the following nematodes: Dictyocaulus viviparus, Bunosto-
mum phlebotomum,  Chabertia ovina, Cooperia curticei,  C.
oncophora/surnabada, C. punctata, Haemonchus contortus,
H. placei, Nematodirus helvetianus, Ostertagia leptospicu-
laris, O. ostertagi/lyrata, O. circumcincta/pinnata/trifurcata,
Oesophagostomum radiatum, Oes. venulosum,  Strongyloides
papillosus,  Trichostrongylus axei, T. capricola, T. colubriformis
and/or Trichuris spp. (sheep origin). Generally, parasites
used were recent ﬁeld isolates as deﬁned per VICH GL 7
(FDA Guidance 90), Effectiveness of anthelmintics: general
recommendations (Vercruysse et al., 2001); however, the
D. viviparus isolate used in Studies 3 and 6 and the O. radia-
tum isolates used in Studies 2–6 were laboratory isolates.
The number of infectious stages administered for each chal-
lenge was in accordance with the WAAVP Guidelines for
Testing of Anthelmintics in Ruminants (Wood et al., 1995).
The inoculation schedule was  designed such that at day of
treatment (=Day 0) nematodes were fourth-stage larvae in
Studies 1–3 and adults or inhibited larvae in Studies 4–6
(Wood et al., 1995). The schedule of inoculation and the
actual number of larvae/eggs administered to each animal
in each study are shown in Table 2.
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Table 1
Animal description and details.
Study Treatmenta/animals
per treatment
Breed Sex ∼Age (months) Pre-treatment
bodyweight (kg)
1 Control n = 8 Holstein Male 5.5 148.0–167.4
EpERI n = 8
2 Control n = 8 Braunvieh (Brown
Swiss)
Male 5.5 109–159
EpERI n  = 8
3 Control n = 8 Limousin, Limousin
cross, Brown Swiss
cross
Male castrate 4–6 122.5–152.5
EpERI n = 8
4 Control n = 8 Holstein Male 5.5 157.6–177.4
EpERI n = 8
5 Control n = 8 Braunvieh (Brown
Swiss)
Male 5 124.5–186.5
EpERI n  = 8
6 Control n = 8 Limousin, Limousin
cross
Male castrate 4–7 129.0–153.5












Sa Control = ERI vehicle-treated; EpERI = eprinomectin ERI.
For all nematode species apart from B. phlebotomum
nd S. papillosus,  suspensions of larvae/eggs were adminis-
ered by oral gavage. To induce B. phlebotomum infections,
hird-stage larvae were administered topically between
he shoulder blades (two studies) or applied into the exter-
al auditory canal (four studies). Infective larvae of S.
apillosus were injected subcutaneously.
.3. Experimental designThe studies were conducted under two identical proto-
ols, i.e., one for Studies 1–3 and one for Studies 4–6, with
 similar study design utilizing a randomized block design
ased on pre-treatment bodyweight. Eight replicates of
able 2
chedule of inoculation and number of larvae/eggs administered per animal.
Day of inoculation/approximate number 
Induction of fourth-stage larval nematod
Study 1 Study 2 Stu
Dictyocaulus viviparus −5/1014 −5/1500 −5/
Bunostomum phlebotomum −14/1092 −14/1500 −13
Chabertia ovina −14/1500 
Cooperia curticei −5/10,000 
Cooperia oncophora/surnabada −7/10,144 −8/10,000 −7/
Cooperia punctata −7/10,130 −8/10,000 
Haemonchus contortus −8/5000 −7/
Haemonchus placei −7/5072 
Nematodirus helvetianus −14/5124 −14/4000 −12
Oesophagostomum radiatum −14/1014 −14/1500 −12
Oesophagostomum venulosum −8/1500 
Ostertagia leptospicularis −8/10,000 
Ostertagia ostertagi/lyrata −7/10,020 −5/10,000 −7/
Ostertagia spp. (sheep origin) −5/8000 
Strongyloides papillosus −5/200,000 
Trichostrongylus axei −7/15,020 −8/10,000 −7/
Trichostrongylus capricola −5/10,000 
Trichostrongylus colubriformis −5/10,054 −5/10,000 
Trichuris spp. (sheep origin)a
a Infective eggs.two  cattle each were formed sequentially, based on pre-
treatment (Day −1/0) bodyweights. Within replicates,
animals were randomly allocated to treatment: one to the
control (ERI vehicle-treated) group and one to the epri-
nomectin ERI group for a total of eight and eight animals
in each group. Assignment of replicates to blocks and of
animals to individual pens or stanchions within blocks was
done at random.
Treatments, vehicle (formulation that consisted of the
excipients of the eprinomectin ERI) as well as epri-
nomectin 5% (w/v) ERI, were administered at 1 mL/50 kg
(1 mL/110 lb) bodyweight once on Day 0 by subcutaneous
injection in front of the shoulder using commercial syringes
and needles.
of infective larvae/eggs administered per animal
es Induction of adult nematodes
dy 3 Study 4 Study 5 Study 6
1500 −28/1017 −28/1500 −28/1500
/1500 −56/1024 −56/1500 −55/1700
−56/1500
−21/10,000




/5000 −28/5046 −28/4000 −28/6000
/1500 −49/1004 −49/1500 −47/1500
−28/1500
−28/10,000
11,000 −28/10,123 −21/10,000 −28/11,000
−21/8000
−12/200,000




S. Rehbein et al. / Veterinary Parasitology 192 (2013) 338– 345 341
Table  3
Therapeutic efﬁcacy of eprinomectin ERI against developing fourth-stage larvae of pulmonary and gastrointestinal nematodes (Studies 1–3).
Study # Control (ERI vehicle) Eprinomectin ERI Efﬁcacyc (%) Probabilityd
Prevalencea GMb Prevalence GM
Dictyocaulus viviparus
1  5/8 4 0/8 0 100 <0.05
2  8/8 282 0/8 0 100 <0.01
3 7/7e 244 0/8 0 100 <0.01
Bunostomum phlebotomum
1  6/8 24 0/8 0 100 <0.05
2 8/8  88 0/8 0 100 <0.01
3  2/7e 2 0/8 0 100 nsf
Cooperia curticei
2 4/8 3 0/8 0 100 <0.05
Cooperia oncophora
1 6/8 378 0/8 0 100 <0.05
2 8/8  2626 3/8 1 >99 <0.01
3  7/7e 5754 0/8 0 100 <0.01
Cooperia punctata
1 8/8 2423 0/8 0 100 <0.05
2  8/8 6982 0/8 0 100 <0.01
Cooperia surnabada
1 7/8 245 0/8 0 100 <0.05
2  8/8 443 3/8 1 >99 <0.01
3  7/7e 461 0/8 0 100 <0.01
Haemonchus contortus
2  8/8 696 0/8 0 100 <0.01
Haemonchus placei
1  8/8 116 0/8 0 100 <0.05
Nematodirus helvetianus
1  5/8 23 0/8 0 100 <0.05
2 8/8  228 0/8 0 100 <0.01
3  6/7e 73 0/8 0 100 <0.01
Oesophagostomum radiatum
1 8/8 63 0/8 0 100 <0.05
2 8/8  521 0/8 0 100 <0.01
3  7/7e 171 0/8 0 100 <0.01
Oesophagostomum venulosum
2 8/8 8 0/8 0 100 <0.01
Ostertagia circumcincta
2 8/8 417 0/8 0 100 <0.01
Ostertagia leptospicularis
2 8/8 4264 0/8 0 100 <0.01
Ostertagia lyrata
1 1/8 <1 0/8 0 100 nsf
3 2/7e 2 0/8 0 100 ns
Ostertagia ostertagi
1 7/8 802 0/8 0 100 <0.05
2  8/8 4769 0/8 0 100 <0.01
3  7/7e 5895 0/8 0 100 <0.01
Ostertagia pinnata
2 4/8 5 0/8 0 100 <0.05
Ostertagia trifurcata
2 6/8 19 0/8 0 100 <0.01
Strongyloides papillosus
2 8/8 943 2/8 1 >99 <0.01
Trichostrongylus axei
1  8/8 1135 0/8 0 100 <0.05
2  8/8 2720 0/8 0 100 <0.01
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Table 3 (Continued)
Study # Control (ERI vehicle) Eprinomectin ERI Efﬁcacyc (%) Probabilityd
Prevalencea GMb Prevalence GM
Trichostrongylus colubriformis
1 6/8 34 0/8 0 100 <0.05
2  7/8 166 0/8 0 100 <0.01
a Prevalence: number of cattle infected/number of cattle in group.
b Geometric mean counts (based on transformation to the natural logarithm of [count + 1]).









































Fd Probability from the Wilcoxon rank sum test.
e One animal removed from control group for humane reasons.
f Not signiﬁcant at  ˛ = 0.05.
All cattle were observed hourly for four hours post-
reatment and thereafter once daily throughout the studies
or health problems or adverse drug events.
All study animals were humanely euthanized and
ecropsied to obtain a total nematode count 14 or 15 days
fter treatment (Studies 4–6) or 21 or 22 days after treat-
ent (Studies 1–3).
.4. Parasite counts
At necropsy, the lungs (with trachea), abomasum,
mall intestine, and large intestine were removed. Total
ungworms were collected either after dissection of all
ccessible air passages and soaking of the dissected lungs
Studies 1, 2, 4 and 5) or by pulmonary tract perfusion
Oakley, 1980; Studies 3 and 6) and counted. The contents
f the abomasum, small intestine, and large intestine
ere collected separately. Abomasum and small intestine
lso were incubated (overnight saline soak at approxi-
ately 38 ◦C) to recover mucosal stages of the parasites
or identiﬁcation and counting. The entire contents or a
nown percentage of each organ (abomasum and small
ntestine contents and soaks: 5% or 10% aliquots; large
ntestine contents: 20% or 25% aliquots or total count) were
xamined and the appropriate dilution factor applied for
nal count. To facilitate isolation and counting of nema-
odes, soaks were screened over 0.025 mm or 0.038 mm
esh sieves, abomasum and small intestine contents were
ashed through 0.038 mm or 0.150 mm mesh sieves, and
arge intestine contents were washed over 0.074 mm,
.150 mm  or 0.300 mm aperture sieves to remove the
ebris.
Counts of each parasite species for each animal were
alculated by multiplying the number of worms actually
ounted in each location by the aliquot factor and summing
ver locations.
After necropsy, nematodes were identiﬁed to species or
enus level and stage of development according to recog-
ized methods and procedures. Adult female nematodes
nd/or fourth-stage larvae were not identiﬁed always to
pecies level. For some genera of nematodes (i.e., Coope-
ia, Ostertagia and Trichostrongylus), the total counts were
stimated by proportionally assigning adult females to
ach species based on the adult male counts. When adult
emales within genera were counted in the presence of
o males, the counts were either proportioned equally or
ssigned based on the species present in other animals.
or Trichostrongylus spp. in two studies, non-speciatednematodes were assigned to species based on the location
in which the nematodes were found.
2.5. Statistical methods
All nematode counts were transformed to the natural
logarithm of (count + 1) for calculation of geometric means.
Treatment groups were compared using the Wilcoxon rank
sum test. A two-sided test was  used at the signiﬁcance level
of 0.05. Efﬁcacy was  calculated as 100[(C − T)/C], where C
is the geometric mean for the control (ERI vehicle-treated)
group and T is the geometric mean for the eprinomectin
ERI treated group.
3. Results
All animals were reported as normal during hourly
observations for four hours post-treatment and there were
no observations indicative for changes of their health in
comparison to their status before treatment, indicating that
treatment, either eprinomectin ERI or ERI vehicle (con-
trol), was  well accepted. There were no drug-related health
problems or adverse drug events observed at any time dur-
ing the studies.
One control animal in Study 3 exhibited severe pneumo-
nia on Days 13–15 (probably due to migrating lungworm
larvae) and did not recover despite treatment with an
antibiotic and a non-steroidal anti-inﬂammatory medica-
tion. It was thus withdrawn from the study for humane
grounds on Day 16 and treated for lungworms with a ben-
zimidazole.
The results for the three studies conducted to assess the
therapeutic efﬁcacy of eprinomectin ERI against (normally)
developing fourth-stage larvae of pulmonary and gastroin-
testinal nematodes are presented in Table 3. Cattle treated
with eprinomectin ERI had signiﬁcantly (p < 0.05) fewer of
the following nematodes than the ERI vehicle-treated con-
trols with overall reduction of nematode counts by >99%: D.
viviparus, B. phlebotomum,  C. curticei, C. oncophora,  C. surn-
abada, C. punctata, H. contortus, H. placei, N. helvetianus, Oes.
radiatum, Oes. venulosum,  O. leptospicularis,  O. ostertagi, O.
circumcincta, O. pinnata, O. trifurcata, S. papillosus,  T. axei,
and T. colubriformis.
The results for the three studies conducted to assess the
therapeutic efﬁcacy of eprinomectin ERI against adult pul-
monary and gastrointestinal nematodes are presented in
Table 4. Cattle treated with eprinomectin ERI had signiﬁ-
cantly (p < 0.05) fewer of the following nematodes than the
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Table  4
Therapeutic efﬁcacy of eprinomectin ERI against adult pulmonary and gastrointestinal nematodes (Studies 4–6).
Study # Control (ERI vehicle) Eprinomectin ERI Efﬁcacyc (%) Probabilityd
Prevalencea GMb Prevalence GM
Dictyocaulus viviparus
4  8/8 21 0/8 0 100 <0.05
5  8/8 198 0/8 0 100 <0.01
6  8/8 113 0/8 0 100 <0.05
Dictyocaulus viviparus, fourth-stage larvae
4 2/8 3 0/8 0 100 nse
Bunostomum phlebotomum
4  8/8 34 0/8 0 100 <0.05
5 8/8  346 0/8 0 100 <0.01
6  8/8 83 0/8 0 100 <0.05
Cooperia curticei
4 6/8 9 0/8 0 100 <0.01
Cooperia oncophora
4 7/8 669 2/8 2 >99 <0.05
5  8/8 3519 2/8 2 >99 <0.01
6 8/8  8117 2/8 2 >99 <0.05
Cooperia punctata
4 7/8 261 1/8 <1 >99 <0.05
5  8/8 4216 4/8 3 >99 <0.01
Cooperia surnabada
4 7/8 142 1/8 <1 >99 <0.05
5  8/8 574 2/8 1 >99 <0.01
6 8/8  717 1/8 <1 >99 <0.05
Cooperia spp., inhibited fourth-stage larvae
4  6/8 19 0/8 0 100 <0.05
6  8/8 283 0/8 0 100 <0.05
Haemonchus contortus
5  8/8 1003 0/8 0 100 <0.01
Haemonchus placei
4  8/8 395 0/8 0 100 <0.05
Haemonchus spp., inhibited fourth-stage larvae
4  7/8 27 0/8 0 100 <0.05
Nematodirus helvetianus
4  3/8 9 0/8 0 100 ns
5  8/8 310 0/8 0 100 <0.01
6  7/8 171 0/8 0 100 <0.05
Nematodirus spp., inhibited fourth-stage larvae
4  7/8 85 0/8 0 100 <0.05
5  8/8 129 0/8 0 100 <0.01
6  7/8 95 0/8 0 100 <0.05
Oesophagostomum radiatum
4 8/8 51 0/8 0 100 <0.05
5  8/8 590 0/8 0 100 <0.01
6  8/8 437 0/8 0 100 <0.05
Oesophagostomum venulosum
5 8/8 17 0/8 0 100 <0.01
Oesophagostomum spp., inhibited fourth-stage larvae
4 2/8 <1 0/8 0 100 ns
Ostertagia circumcincta
5 8/8 405 0/8 0 100 <0.01
Ostertagia leptospicularis
5 8/8 3263 0/8 0 100 <0.01
Ostertagia lyrata
4 2/8 2 1/8 <1 79 nse
6 6/8 26 1/8 <1 99 <0.05
Ostertagia ostertagi
4 8/8 3367 1/8 <1 >99 <0.05
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Table 4 (Continued)
Study # Control (ERI vehicle) Eprinomectin ERI Efﬁcacyc (%) Probabilityd
Prevalencea GMb Prevalence GM
5 8/8 3161 0/8 0 100 <0.01
6  8/8 5897 1/8 <1 >99 <0.05
Ostertagia pinnata
5 5/8 7 0/8 0 100 <0.05
Ostertagia trifurcata
5 3/8 3 0/8 0 100 ns
Ostertagia spp., inhibited fourth-stage larvae
4 5/8 9 0/8 0 100 <0.05
5 8/8  900 0/8 0 100 <0.01
Strongyloides papillosus
5  8/8 6652 7/8 112 98 <0.01
Trichostrongylus axei
4 8/8 1768 0/8 0 100 <0.05
5 8/8  1972 0/8 0 100 <0.01
Trichostrongylus axei, inhibited fourth-stage larvae
4  2/8 1 0/8 0 100 ns
Trichostrongylus colubriformis
4 6/8 41 0/8 0 100 <0.05
5  8/8 232 0/8 0 100 <0.01
Trichuris ovis
5 8/8 17 0/8 0 100 <0.01
a Prevalence: number of cattle infected/number of cattle in group.
b Geometric mean counts (based on transformation to the natural logarithm of [count + 1]).

























oProbability from the Wilcoxon rank sum test.
e Not signiﬁcant at  ˛ = 0.05.
ehicle-treated controls with overall reduction of nema-
ode counts by ≥98%: D. viviparus, B. phlebotomum,  C.
urticei, C. oncophora,  C. surnabada,  C. punctata, H. contor-
us, H. placei,  N. helvetianus, Oes. radiatum, Oes. venulosum,
. circumcincta, O. leptospicularis,  O. ostertagi, O. circum-
incta, O. pinnata, S. papillosus,  T. axei, T. colubriformis
nd Trichuris ovis. In addition, 100% efﬁcacy (p < 0.05) was
stablished against inhibited fourth-stage larvae of Coope-
ia spp., Haemonchus spp., Nematodirus spp. and Ostertagia
pp.
Examination of collected organs after necropsy revealed
hat Chabertia ovina and T. capricola in Studies 2 and 5, and
. contortus and T. axei in Studies 3 and 6 did not become
stablished in the controls.
. Discussion
As demonstrated by the geometric mean numbers of
ematodes found at necropsy in the controls, inoculation
f most species produced adequate infections as suggested
y VICH for bovines (Vercruysse et al., 2001) in the majority
f occasions. However, in some instances, e.g. O. lyrata,  very
ow parasite counts and insufﬁcient numbers of the con-
rols harboring the parasite did not allow for meaningful
nalyses to be performed.Eprinomectin in the extended-release injection formu-
ation is highly efﬁcacious against a broad spectrum of
astrointestinal and lung nematode species of cattle. Most
f the species tested were eliminated completely fromthe treated cattle. Similar results were obtained by using
eprinomectin in a 0.5% topical formulation at 0.5 mg  epri-
nomectin/kg bodyweight (Pitt et al., 1997). Furthermore,
the results of the studies reported here are in agreement
with the titration experiments conducted by Shoop et al.
(2001) who  recorded ≥99% reduction of the worm burden
in calves treated with an experimental injectable for-
mulation of eprinomectin at 0.1 mg/kg bodyweight when
compared to the burden of vehicle-treated controls. The
spectrum of parasites tested by Shoop et al. (2001) included
also C. oncophora,  N. helvetianus and T. colubriformis which
have been demonstrated to be dose-limiting parasites for
the earlier avermectins and moxidectin at their commer-
cialized use levels and formulations (Vercruysse and Rew,
2002).
In conclusion, on the basis of the data reported here,
eprinomectin formulated as an extended-release injection
was  highly efﬁcacious against the complete range of nema-
tode parasites of grazing and/or stabled cattle, and thus,
treatment will eliminate adult and larval endoparasite
infections present at the time of treatment. These results,
together with the excellent efﬁcacy against infections
experimentally induced up to 150 days after treatment
(Soll et al., 2013) and in grazing cattle exposed to nat-
ural gastrointestinal and pulmonary nematode challenge
for 120 days (Kunkle et al., 2013; Rehbein et al., 2013),
demonstrated that treatment with eprinomectin ERI will
provide an effective control of gastrointestinal and pul-
monary nematodes of cattle for extended periods.
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Conﬂict of interest
All authors are current employees of Merial and assisted
with the study design, conduct, data analysis and review of
the manuscript.
Acknowledgment
The work reported herein was funded by Merial Limited,
GA, USA.
References
Baggott, D.G., Batty, A.F., Timms, B.J., 1999. Comparison of eprinomectin
with other macrocyclic lactones in cattle. In: Abstracts of the 17th
International Conference of the World Association for the Advance-
ment of Veterinary Parasitology, Copenhagen, Denmark, 15–19
August 1999, c.7.38.
Barth, D., Hair, J.A., Kunkle, B.N., Langholff, W.K., Löwenstein, M.,  Rehbein,
S.,  Smith, L.L., Eagleson, J.S., Kutzer, E., 1997. Efﬁcacy of eprinomectin
against mange mites in cattle. Amer. J. Vet. Res. 58, 1257–1259.
Batty, A.F., Baggott, D.G., Langholff, W.K., Timms, B.J., Pitt, S.R., 1999. Use of
eprinomectin to control nematodes in grazing cattle. In: Proceedings
of the 26th World Veterinary Congress, Lyon, France, CD-ROM, 23–29
September 1999.
Campbell, J.B., Boxler, D.J., Davis, R.L., 2001. Comparative efﬁcacy of several
insecticides for control of cattle lice (Mallophaga: Trichodectidae and
Anoplura: Haematopinidae). Vet. Parasitol. 96, 155–164.
Clark, S.L., Crowley, A.J., Schmidt, P.G., Donoghue, A.R., Piché, C.A.,
2004. Long-term delivery of ivermectin by use of poly(d,l-lactide-co-
glycolic)acid microparticles in dogs. Amer. J. Vet. Res. 65, 752–757.
Cramer, L.G., Pitt, S.R., Rehbein, S., Gogolewski, R.P., Kunkle, B.N., Langholff,
W.K., Bond, K.A., Maciel, A.E., 2000. Persistent efﬁcacy of topical epri-
nomectin against nematode parasites in cattle. Parasitol. Res. 86,
944–946.
Dorny, P., Demeulenaere, D., Smets, K., Vercruysse, J., 2000. Control of gas-
trointestinal nematodes in ﬁrst season grazing calves by two strategic
treatments with eprinomectin. Vet. Parasitol. 89, 277–286.
Epe, C., Woidtke, S., Pape, M.,  Heise, M.,  Kraemer, F., Kohlmetz, C.,
Schnieder, T., 1999. Strategic control of gastrointestinal nematode and
lungworm infections with eprinomectin at turnout and eight weeks
later. Vet. Rec. 144, 380–382.
Gogolewski, R.P., Pitt, S.R., Thompson, D.R., Langholff, W.K., Hair, J.A., Ful-
ton, R.K., Allerton, G.R., Eagleson, J.S., 1997a. Effect of simulated rain,
coat length and exposure to natural climatic conditions on the efﬁ-
cacy of a topical formulation of eprinomectin against endoparasites
of cattle. Vet. Parasitol. 69, 95–102.
Gogolewski, R.P., Slacek, B., Familton, A.S., Paterson, B., Langholff, W.K.,
Allerton, G.R., McAnulty, R., Eagleson, J.S., 1997b. Efﬁcacy of a topical
formulation of eprinomectin against endoparasites of cattle in New
Zealand. New Zealand Vet. J. 45, 1–3.
Holste, J.E., Bowman, D., Wallace, D., Cramer, L., Maciel, A., Soll, M.,  2002.
Persistent activity of eprinomectin against trickle infections of Coope-
ria  species in cattle. In: Abstracts of the 22nd World Buiatrics Congress,
Hannover, Germany, 18–23 August 2002, p. 159.
Holste, J.E., Colwell, D.D., Kumar, R., Lloyd, J.E., Pinkall, N.P.M., Sierra, M.A.,
Waggoner, J.W., Langholff, W.K., Barrick, R.A., Eagleson, J.S., 1998. Efﬁ-
cacy of eprinomectin against Hypoderma spp. in cattle. Amer. J. Vet.
Res. 59, 56–58.
Holste, J.E., Smith, L.L., Hair, J.A., Lancaster, J.L., Lloyd, J.E., Langholff, W.K.,
Barrick, R.A., Eagleson, J.S., 1997. Eprinomectin: a novel avermectin
for  control of lice in all classes of cattle. Vet. Parasitol. 73, 153–161.Kunkle, B.N., Williams, J.C., Johnson, E.G., Stromberg, B.E., Yazwinski,
T.A., Smith, L.L., Yoon, S., Cramer, L.G., 2013. Therapeutic and per-
sistent (120 day) duration of efﬁcacy, acceptability, and productivity
of  extended-release injectable eprinomectin when used under ﬁeld
conditions. Vet Parasitol. 192, 332–337.ology 192 (2013) 338– 345 345
Lewis, D.H., 1990. Controlled release of bioactive agents from lac-
tide/glycolide polymers. In: Chasin, M.,  Langer, R. (Eds.), Biodegrad-
able Polymers as Drug Delivery Systems. Marcel Dekker Inc., New
York, pp. 1–41.
Miller, J.A., Davey, R.B., Oehler, D.D., Pound, J.M., George, J.E., Ahrens, E.H.,
1999. Control of Boophilus annulatus (Acari: Ixodidae) using injectable
microspheres containing ivermectin. J. Econ. Entomol. 92, 1142–1146.
Oakley, G.A., 1980. The recovery of Dictyocaulus viviparus from bovine
lungs by perfusion: a modiﬁcation of Inderbitzin’s method. Res. Vet.
Sci.  29, 395–396.
Pitt, S.R., Langholff, W.K., Eagleson, J.S., Rehbein, S., 1997. The efﬁcacy
of eprinomectin against induced infections of immature (fourth lar-
val stage) and adult nematode parasites in cattle. Vet. Parasitol. 73,
119–128.
Rehbein, S., Pitt, S.R., Rossi, L., Pollmeier, M.,  2005. Efﬁcacy of eprinomectin
against Linognathus vituli and Bovicola bovis on calves. Vet. Rec. 156,
112–113.
Rehbein, S., Baggott, D.G., Johnson, E.G., Kunkle, B.N., Yazwinski, T.A., Yoon,
S., Cramer, L.G., Soll, M.D., 2013. Nematode burdens of pastured cattle
treated once at turnout with eprinomectin extended-release injection.
Vet Parasitol. 192, 321–331.
Schoett, S., Wilhelm, G., Ilchmann, G., 2002. Eradication of chorioptic
mange in two  dairy farms. In: Abstracts of the 22nd World Buiatrics
Congress, Hannover, Germany, 18–23 August 2002, p. 154.
Schönberg, J., Ilchmann, G., Schein, E., 2000. Versuch der Tilgung der Chori-
optes bovis-Räude in einem Milchviehbestand mit Weidehaltung mit
Eprinex Pour-On. Berl. Münch. Tierärztl. Wschr. 113, 144–148.
Shoop, W.L., Egerton, J.R., Eary, C.H., Haines, H.W.,  Michael, B.F., Mrozik,
H.,  Eskola, P., Fisher, M.H., Slayton, L., Ostlind, D.A., Skelly, B.J., Ful-
ton, R.K., Barth, D., Costa, S., Gregory, L.M., Campbell, W.C., Seward,
R.L., Turner, M.J., 1996. Eprinomectin: a novel avermectin for use as a
topical endectocide for cattle. Int. J. Parasitol. 26, 1237–1242.
Shoop, W.,  Michael, B., Egerton, J., Mrozik, H., Fisher, M.,  2001. Titration
of  subcutaneously administered eprinomectin against mature and
immature nematodes in cattle. J. Parasitol. 87, 1466–1469.
Shoop, W.,  Soll, M., 2002. Ivermectin, abamectin and eprinomectin. In:
Vercruysse, J., Rew, R. (Eds.), Macrocyclic Lactones in Antiparasitic
Therapy. CABI Publishing, Oxon, UK, pp. 1–29.
Soll, M.D., Kunkle, B.N., Royer, G.C., Yazwinski, T.A., Baggott, D.G., Wehner,
T.A., Yoon, S., Cramer, L.G., Rehbein, S., 2013. Eprinomectin extended-
release injection – a new formulation developed to provide nematode
control in cattle for up to 150 days. Vet Parasitol. 192, 313–
320.
Vercruysse, J., Holdsworth, P., Letonja, T., Barth, D., Conder, G., Hamamoto,
K., Okano, K., 2001. International harmonisation of anthelmintic efﬁ-
cacy guidelines. Vet. Parasitol. 96, 171–193.
Vercruysse, J., Rew, R., 2002. General efﬁcacy of the macrocyclic lactones
to  control parasites of cattle. In: Vercruysse, J., Rew, R. (Eds.), Macro-
cyclic Lactones in Antiparasitic Therapy. CABI Publishing, Oxon, UK,
pp. 185–222.
Watson, C.L., Forbes, A.B., 2000. An outbreak of sarcoptic mange in dairy
cows. UK Vet. Livestock 5, 48–50.
Williams, J.C., Stuedemann, J.A., Bairden, K., Kerboeuf, D., Ciordia, H.,
Hubert, J., Broussard, S.D., Plue, R.E., Alva-Valdes, R., Baggott, D.G.,
Pinkall, N., Eagleson, J.S., 1997. Efﬁcacy of a pour-on formulation of
eprinomectin (MK-397) against nematode parasites of cattle, with
emphasis on inhibited early fourth-stage larvae of Ostertagia spp.
Amer. J. Vet. Res. 58, 379–383.
Winzenburg, G., Schmidt, C., Fuchs, S., Kissel, T., 2004. Biodegradable poly-
mers and their potential use in parenteral veterinary drug delivery
systems. Adv. Drug Deliv. Syst. 56, 1453–1466.
Wood, I.B., Amaral, N.K., Bairden, K., Duncan, J.L., Kassai, T., Malone Jr.,
J.B., Pankavich, J.A., Reinecke, R.K., Taylor, S.M., Vercruysse, J., 1995.
World Association for the Advancement of Veterinary Parasitology
(W.A.A.V.P.) second edition of guidelines for evaluating the efﬁcacy of
anthelmintics in ruminants (bovine, ovine, caprine). Vet. Parasitol. 58,
181–213.
Yazwinski, T.A., Johnson, E.G., Thompson, D.R., Drag, M.D., Zimmerman,
G.L., Langholff, W.K., Holste, J.E., Eagleson, J.S., 1997. Nematocidal efﬁ-
cacy of eprinomectin, delivered topically, in naturally infected cattle.
Amer. J. Vet. Res. 58, 612–614.
